CPHA Canvax

This document provides guidance on the use of booster COVID-19 vaccine doses in adolescents 12-17 years of age. 

Additional Authors: Nicole Forbes, Bryna Warshawsky, Kelsey Young, Matthew C. Tunis, Beate Sander, and Shelly Deeks

Additional Resource: 

Rating See Comments Ratings

Category:

Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Research and Development,Vaccine Effectiveness and Efficacy,Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Specific Populations,Children,Adolescents,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Specific Populations
Children
Adolescents
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.